J. Martin Carroll, Director at Esperion Therapeutics, Inc. (ESPR), bought 5,000 shares at $5.64 ($28K) on 2022-06-02, disclosed to the SEC on 2022-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| MNK | BUY | 2017-11-13 | $204K | — | Filing → |
| ITEK | BUY | 2016-05-17 | $90K | — | Filing → |
| TXMD | BUY | 2015-05-12 | $61K | — | Filing → |